Levothyroxine manufacturers
Pro Research Analysisby 
Searched over 200M research papers for "levothyroxine manufacturers"
Levothyroxine Manufacturers and Marketed Brands
Levothyroxine, a synthetic thyroid hormone, is produced by several manufacturers worldwide. Commonly available brands include Synthroid (Abbott), Eltroxin (GlaxoSmithKline), Thyronorm (Abbott India), and Lethyrox (Intas Pharmaceuticals), among others. The market also features multiple generic versions, with at least eight levothyroxine products available in the US alone, produced by both brand-name and generic manufacturers Dave2024Gebhart2005Sattar2022.
Brand and Generic Levothyroxine: Clinical Equivalence and Switching
Impact of Switching Between Brands and Generics
Research shows that switching between different brands or generic manufacturers of levothyroxine generally does not lead to clinically significant changes in thyroid-stimulating hormone (TSH) levels for most patients. Large studies in both India and the US found that the majority of patients maintained normal TSH levels after switching brands or generics, and dose adjustments were rarely needed Dave2024Brito2022. These findings challenge earlier concerns and some clinical guidelines that warned about potential TSH fluctuations when switching between manufacturers .
Regulatory and Clinical Concerns
Despite evidence supporting the safety of switching, some professional endocrinology associations have criticized regulatory protocols for establishing bioequivalence. Concerns include the use of healthy volunteers instead of patients with hypothyroidism and the focus on serum thyroxine (T4) rather than TSH levels. There is also worry that small differences in formulation could impact vulnerable populations, such as the elderly, pregnant women, and children. As a result, some experts recommend monitoring TSH levels after any switch and maintaining patients on the same preparation when possible .
Physicochemical Properties and Quality Control Among Manufacturers
Comparative studies of levothyroxine tablets from different manufacturers show slight differences in properties such as weight, thickness, hardness, and disintegration time. However, these differences generally fall within accepted pharmacopeial standards (BP and USP), suggesting that the products are pharmaceutically equivalent. Nonetheless, further studies on drug release and bioequivalence are recommended to ensure consistent therapeutic outcomes .
Excipients and Stability in Levothyroxine Tablets
The stability of levothyroxine tablets can be affected by the choice of excipients used by different manufacturers. Some excipients, like lactose, starch, or microcrystalline cellulose, may lead to reduced potency over time, especially under high temperature and humidity. In contrast, formulations using dibasic calcium phosphate with basic pH modifiers (such as sodium carbonate or magnesium oxide) show improved stability and maintain potency for longer periods . This highlights the importance of formulation choices in ensuring product quality across manufacturers.
Conclusion
Levothyroxine is produced by multiple manufacturers, offering both brand-name and generic options. Most evidence indicates that switching between different manufacturers' products is safe and does not significantly affect thyroid hormone control in the majority of patients. However, differences in formulation and excipients can impact tablet stability and, in rare cases, clinical outcomes. Ongoing monitoring and quality control remain important, especially for vulnerable patient groups.
Sources and full results
Most relevant research papers on this topic